<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00160888</url>
  </required_header>
  <id_info>
    <org_study_id>K004</org_study_id>
    <nct_id>NCT00160888</nct_id>
  </id_info>
  <brief_title>Vasoreactivity in Carriers of Genetic Polymorphisms</brief_title>
  <official_title>Endothelium-Dependent Vasoreactivity in Nitric Oxide Synthase Gene (Glu298Asp) Polymorphism: Studies in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <brief_summary>
    <textblock>
      The objective of the study is to assess the impact of genetic variation (especially
      polymorphisms of the gene coding endothelial nitric oxide synthase (eNOS) and the bradykinin
      B2 receptor gene) on venous and arterial responsiveness to vasodilators in healthy
      individuals without cardiovascular risk factors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study I: Using the dorsal hand vein compliance technique dose-response curves to bradykinin
      and sodium nitroprusside will be obtained in healthy volunteers during preconstriction with
      phenylephrine and after pretreatment with a single dose of 500 mg i.v. acetylsalicylic acid.

      Study II: Using venous occlusion plethysmography dose-response curves to acetylcholine,
      sodium nitroprusside and L-NG-monomethyl-arginine (L-NMMA) will be obtained in healthy
      volunteers pretreated with a single dose of 500mg i.v. acetylsalicylic acid.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 1999</start_date>
  <completion_date>December 2006</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Educational/Counseling/Training</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Study I: Venous responsiveness assessed by dorsal hand vein compliance technique</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Study II: Forearm blood flow assessed by venous occlusion plethysmography</measure>
  </primary_outcome>
  <enrollment>100</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium nitroprusside, bradykinin, acetylcholine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age: 18 – 70

          -  gender: male

          -  good state of health

        Exclusion Criteria:

          -  known condition causing endothelial dysfunction (e.g. diabetes, hyperlipidaemia,
             arterial hypertension, smoking, homocysteinemia)

          -  regular medication and/or treatment with drugs within the last 4-6 weeks (exclusion
             has to be decided in each case)

          -  acute or chronic illness

          -  methylxanthines and alcohol during 12 hours before the study

          -  nicotine during 1 year before the study

          -  drug and/or alcohol abuse

          -  pregnancy or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Walter E Haefeli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Internal Medicine VI, University of Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Walter E Haefeli, MD</last_name>
    <phone>+49-6221-56-</phone>
    <phone_ext>8740</phone_ext>
    <email>Walter_Emil_Haefeli@med.uni-heidelberg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dept. of Internal Medicine VI</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Württemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Fricker R, Hesse C, Weiss J, Tayrouz Y, Hoffmann MM, Unnebrink K, Mansmann U, Haefeli WE. Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation. Br J Clin Pharmacol. 2004 Aug;58(2):169-77.</citation>
    <PMID>15255799</PMID>
  </reference>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>September 9, 2005</last_update_submitted>
  <last_update_submitted_qc>September 9, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 12, 2005</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroprusside</mesh_term>
    <mesh_term>Acetylcholine</mesh_term>
    <mesh_term>Bradykinin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

